Bryan Cave Helps Sigma-Aldrich In $350M Deal
Science and technology company Sigma-Aldrich Corp. has expanded its reach into testing services, purchasing biopharmaceutical testing provider BioReliance Holdings Inc. from Avista Capital Partners for $350 million, the buyer announced Monday....To view the full article, register now.
Already a subscriber? Click here to view full article